3/5/26  Benefits of HBOT (Hyperbaric Oxygen Therapy)   Author: Jeremy Smith & Google Gemini

1. Cellular Aging & Telomeres

HBOT is the first intervention demonstrated to reverse the cellular hallmarks of aging in humans by extending telomeres and clearing "zombie" cells.

• Telomere Extension: Telomeres, which typically shorten by 20–40 bases per year, increased across all cell types by over 20% following the 60-session protocol (Hachmo et al., 2020).

• Cell-Specific Increases:

  • B-Cells: 37.63% increase (peak of 29.39% at 60 sessions).

  • T-Helper (CD4+): 20.10% increase.

  • T-Cytotoxic (CD8+): 25.54% increase.

  • Natural Killer (NK) Cells: 20.35% increase.

• Senescence Reduction: Senescent cells, which drive systemic "inflammaging," were significantly reduced (Hachmo et al., 2020).

  • T-Helper Senescent Cells: Decreased by 37.30%.

  • T-Cytotoxic Senescent Cells: Decreased by 10.96%.

2. Regenerative Stem Cell Mobilization

HBOT triggers the bone marrow to release high concentrations of repair cells into the bloodstream.

• CD34+ Stem Cells: A single 2-hour session at 2.0 ATA doubled (100% increase) circulating stem cells; after 20 sessions, they increased by 800% (8-fold) (Thom et al., 2005).

• Nitric Oxide (NO): Bone marrow NO increased by 1,008 nM, acting as the chemical trigger for stem cell release.

• Immune Rebalancing: Total lymphocyte count increased by 31.78%, while the Neutrophil-to-Lymphocyte Ratio (NLR) improved by 18.98% to 55.56%, indicating reduced systemic stress.

3. Cognitive & Brain Health

By increasing cerebral blood flow (CBF), HBOT enhances cognitive performance and may slow the progression of decline.

• Cerebral Blood Flow: Significant increases of 5% to 10% in key regions such as BA10 and BA6.

• Global Cognitive Function: Large effect size improvement (0.849) (Hadanny et al., 2020).

  • Attention: Effect size of 0.745.(considered a large effect… means the average participant in the HBOT group performed better than roughly 77% of the participants in the control group)

  • Information Processing Speed: Effect size of 0.788. (this is very close to the threshold of a "large" effect … indicating a major shift in the speed at which the brain processed new data compared to the baseline and the control group)

• Mild Cognitive Impairment (MCI): 2024 cohort data suggests the protocol significantly slows MCI progression by repairing vascular pathways in the brain.

4. Skin Rejuvenation

HBOT impacts the structural integrity and cellular age of the skin (Hachmo et al., 2021).

• Elastic Fiber Length: Increased by an "extreme" effect size of 2.71 (over 99th percentile improvement).

• Collagen Density: Increased by a large effect size of 1.1 (placing the average participant in the top 86% of the baseline group).

• Senescent Skin Cells: Significantly reduced with an effect size of 0.84.

5. Cardiac Efficiency (Heart Function)

HBOT improves heart pumping efficiency and triggers angiogenesis in cardiac tissue.

• Cardiac Torsion (Twist): Increased from 18.32° to 23.12°.

• Ejection Fraction (LVEF): Increased from 60.71% to 62.29% ; improved in patients with heart failure.

• Myocardial Blood Flow (MBF): Large net effect size of 0.797.

• Myocardial Blood Volume (MBV): Large net effect size of 0.896.

• VO2 Max: Significant increase of $1.91\pm3.29$ ml/kg/min.

• End Systolic Volume: Decreased from 38.08 ml to 35.39 ml.

• Myocardial Performance Index: Improved from 0.29 to 0.26.

• Inflammatory Markers: Systemic reductions in Ferritin (-0.066 coefficient) and C-Reactive Protein (-0.077 coefficient).

6. Metabolic & Mitochondrial Health

HBOT facilitates a "re-powering" of cells by activating energy pathways and stimulating the creation of new mitochondria.

• ATP & NAD+: HBOT activates the ATP/NAD+/SIRT1 pathway and attenuates the decline of these levels in energy-depleted tissues.

• Mitochondrial Biogenesis: mtDNA content increased by approximately 300% (3-fold) in high-energy tissues. This is driven by the upregulation of "gas pedal" genes like TFAM and NRF-1/2.

• Oxidative Phosphorylation: Genes involved in the Electron Transport Chain were significantly modulated to improve respiratory efficiency.

7. Transcriptomic & Genetic Shifts

A transcriptome analysis revealed that 1,912 genes were significantly altered post-HBOT—1,342 upregulated and 570 downregulated. (Hadanny et al., 2021)

• Sirtuins: Increased expression of SIRT1, which promotes DNA repair and mitochondrial biogenesis.

• HIF-1α: Air breaks stabilize the HIF-1α protein, which acts as a "master switch" for angiogenesis and stem cell proliferation.

• ABCA13: Significant decrease (Fold Change of -2.28, and still -1.54 two weeks later). High expression is associated with age-related pathologies.

• DNAJ6: Downregulated (-2.16 fold change), suggesting reduced proteostatic stress and "clogging" of cells with misfolded proteins.

8. Systemic Symptom Relief

HBOT provides measurable improvements in chronic pain and overall quality of life.

• Fibromyalgia Pain: Large-to-extreme effect size for pain relief with a Standardized Mean Difference (SMD) of -1.56.

• Quality of Life: SF-36 scale scores improved by 10 to 20 points.

9. Inflammation and Cytokines

Studies on the "cytokine storm" and chronic inflammation show that HBOT inhibits the synthesis of pro-inflammatory markers.

• IL-1β: Synthesis inhibited by 23% after a 90-minute exposure.

• TNF-α: Inhibited by 27-29% depending on the stimulus.

• Interferon-gamma (IFN-γ): Significant reduction noted in COVID-19 related "cytokine storm" cases, though percentages vary by baseline severity.

10. Gene Expression: A transcriptome analysis post-HBOT showed 1,912 genes were significantly altered—specifically those related to inflammation, mitochondrial metabolism, and the immune response. Of those, 1,342 genes were Upregulated (Turned Up), and 570 Downregulated (Turned Down).

Mitochondrial Metabolism (The Energy Shift)

The most profound shift occurred in how cells produce energy. Aging is often defined by "mitochondrial decay," where the cell's power plants become leaky and inefficient.

• Mitochondrial Biogenesis: The study noted an upregulation in genes responsible for creating new mitochondria.

• The Result: This implies the cells were essentially being "re-powered," moving from a state of low-energy survival to high-energy repair.

• Oxidative Phosphorylation: Genes involved in the Electron Transport Chain (the process of making ATP) were significantly modulated, suggesting a "tuning" of cellular respiration to be more efficient.

• Specific Downregulation (ABCA13): As mentioned previously, ABCA13 saw a significant decrease (Fold Change of -2.28, and still 1.54 two weeks after). High expression of this gene is often associated with age-related pathologies and metabolic dysfunction; turning it down is considered a "pro-youth" move.

Inflammation and Immune Response

Aging is associated with "inflammaging"—a state of chronic, low-grade systemic inflammation. The transcriptome analysis showed that HBOT acted as a powerful anti-inflammatory "brake."

• Cytokine Signaling: There was a marked downregulation of genes responsible for pro-inflammatory cytokines. In older adults, genes related to cytokine production and chemokine signaling are usually stuck in the "on" position. HBOT significantly downregulated these pathways.

• The "Immune Refresh": The upregulated genes were heavily concentrated in pathways related to T-cell activation and B-cell development. This correlates with the telomere study, where B-cells saw the most dramatic lengthening ($37.63\%$).

• Specific Genes Downregulated: * ABCA13 (FC = -2.28): Strongly linked to various age-related pathologies.

  • DNAJ6 (FC = -2.16): Involved in protein folding; its downregulation suggests a shift in how the cell manages protein stress.

The "Hormetic" Mechanism

The researchers concluded that these 1,912 changes are triggered by hormesis—the biological phenomenon where a "beneficial stressor" triggers a repair response.

• HIF-1α (Hypoxia-Inducible Factor): Although the study uses high oxygen, the "air breaks" (the 5-minute gaps) cause a rapid relative drop in oxygen. This stabilizes the HIF-1α protein, which then enters the cell nucleus and acts as a "master switch" for hundreds of these 1,912 genes. These genes stimulate angiogenesis (new blood vessel growth) and stem cell proliferation. By upregulating these, the study effectively moved the tissue toward a regenerative "fetal-like" or "youthful" state.

• Sirtuins: The analysis showed an increase in the expression of SIRT1, often called the "longevity gene," which helps repair DNA and regulate cellular health. SIRT1 is a NAD+-dependent deacetylase that promotes DNA repair and mitochondrial biogenesis. In aging, SIRT1 levels usually drop; HBOT forces them up.

Summary of Significant Genetic Changes

Category

Primary Gene Action

Impact on Your Biology

Metabolism

Upregulation of ATP synthesis genes

Increased cellular energy and repair capacity.

Inflammation

Downregulation of cytokine signaling

Reduction in "inflammaging" and systemic stress.

Longevity

Upregulation of SIRT1 and Telomerase

Potential for DNA repair and cellular "age reversal."

Structure

Modulation of ABCA13 and DNAJ6

Improved protein handling and lipid metabolism.

The 570 Downregulated Genes (The "Brake" on Aging)

The genes that were turned "down" were largely associated with inflammation and cellular senescence (the "zombie cell" state).

• Protein Folding (DNAJ6): This gene, involved in chaperone-mediated protein folding, was downregulated (FC = -2.16). This suggests the cells were under less "proteostatic stress"—the clogging of cells with misfolded proteins that occurs in old age.

Comprehensive Roundup of Hyperbaric Oxygen Therapy (HBOT) Benefits

1. Cellular Aging & Telomeres

HBOT is the first intervention demonstrated to reverse the cellular hallmarks of aging in humans by extending telomeres and clearing "zombie" cells.

• Telomere Extension: Telomeres, which typically shorten by 20–40 bases per year, increased across all cell types by over 20% following the 60-session protocol (Hachmo et al., 2020).

• Cell-Specific Increases:

  • B-Cells: 37.63% increase (peak of 29.39% at 60 sessions).

  • T-Helper (CD4+): 20.10% increase.

  • T-Cytotoxic (CD8+): 25.54% increase.

  • Natural Killer (NK) Cells: 20.35% increase.

• Senescence Reduction: Senescent cells, which drive systemic "inflammaging," were significantly reduced (Hachmo et al., 2020).

  • T-Helper Senescent Cells: Decreased by 37.30%.

  • T-Cytotoxic Senescent Cells: Decreased by 10.96%.

2. Regenerative Stem Cell Mobilization

HBOT triggers the bone marrow to release high concentrations of repair cells into the bloodstream.

• CD34+ Stem Cells: A single 2-hour session at 2.0 ATA doubled (100% increase) circulating stem cells; after 20 sessions, they increased by 800% (8-fold) (Thom et al., 2005).

• Nitric Oxide (NO): Bone marrow NO increased by 1,008 ± 255 nM, acting as the chemical trigger for stem cell release.

• Immune Rebalancing: Total lymphocyte count increased by 31.78%, while the Neutrophil-to-Lymphocyte Ratio (NLR) improved by 18.98% to 55.56%, indicating reduced systemic stress.

3. Cognitive & Brain Health

By increasing cerebral blood flow (CBF), HBOT enhances cognitive performance and may slow the progression of decline.

• Cerebral Blood Flow: Significant increases of 5% to 10% in key regions such as BA10 and BA6.

• Global Cognitive Function: Large effect size improvement (0.849) (Hadanny et al., 2020).

  • Attention: Effect size of 0.745.

  • Information Processing Speed: Effect size of 0.788.

• Mild Cognitive Impairment (MCI): 2024 cohort data suggests the protocol significantly slows MCI progression by repairing vascular pathways in the brain.

4. Dermatological Rejuvenation

HBOT impacts the structural integrity and cellular age of the skin (Hachmo et al., 2021).

• Elastic Fiber Length: Increased by an "extreme" effect size of 2.71 (over 99th percentile improvement).

• Collagen Density: Increased by a large effect size of 1.1 (placing the average participant in the top 86% of the baseline group).

• Senescent Skin Cells: Significantly reduced with an effect size of 0.84.

5. Cardiac & Metabolic Efficiency

Systemic improvements were noted in heart pumping efficiency and mitochondrial energy production.

• Heart Function:

  • Cardiac Torsion (Twist): Improved from 18.32° to 23.12°.

  • Ejection Fraction (LVEF): Increased from 60.71% to 62.29%.

  • Myocardial Blood Flow: Large effect size of 0.797.

• Inflammatory Markers: Systemic reductions in Ferritin (-0.066 coefficient) and C-Reactive Protein (-0.077 coefficient).

• Mitochondrial Biogenesis: Mitochondrial DNA (mtDNA) increased by 300% (3-fold), driven by the upregulation of TFAM and NRF-1/2 "gas pedal" genes.

6. Transcriptomic & Genetic Shifts

A transcriptome analysis revealed that 1,912 genes were significantly altered post-HBOT, flipping molecular switches toward a "youthful" state (Hadanny et al., 2021).

• Upregulated (1,342 Genes): Primarily related to SIRT1 (longevity gene) and oxidative phosphorylation (energy production).

• Downregulated (570 Genes): Primarily related to ABCA13 (metabolic dysfunction) and DNAJ6 (proteostatic stress).

• ABCA13: Saw a peak decrease of -2.28 fold change, remaining at -1.54 two weeks after the protocol ended.

• DNAJ6: Decreased by -2.16 fold change, suggesting cells are under less stress from misfolded proteins.

7. Systemic Symptom Relief

HBOT provides measurable improvements in chronic pain and overall quality of life.

Fibromyalgia Pain: Showed a large-to-extreme effect size for relief with a Standardized Mean Difference (SMD) of -1.56.